Anti-cancer effects of enteric-coated polymers containing mistletoe lectin in murine melanoma cells in vitro and in vivo

Molecular and Cellular Biochemistry

Volumn 408, Issue 1-2, 2015, Pages 73-87

  Han, Seung Yeon ^a   Hong, Chang Eui ^b   Kim, Hwan Gyu ^b   Lyu, Su Yun ^a,c  

^a Sunchon National University   (South Korea)

^b Chonbuk National University   (South Korea)

^c Suncheon Research Center for Natural Medicines   (South Korea)

Author keywords

Apoptosis; Enteric coating; Melanoma; Mistletoe lectin

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; EUDRAGIT; INTERLEUKIN 1BETA CONVERTING ENZYME; PROCASPASE 3; PROCASPASE 8; UNCLASSIFIED DRUG; VISCUM ALBUM COLORATUM AGGLUTININ; VISCUM ALBUM EXTRACT; VISCUM ALBUM LECTIN; PLANT EXTRACT; PLANT LECTIN; POLYMER; RIBOSOME INACTIVATING PROTEIN; SAMBUCUS NIGRA LECTINS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENTERIC COATED TABLET; FEMALE; FOOD INTAKE; G1 PHASE CELL CYCLE CHECKPOINT; IN VITRO STUDY; IN VIVO STUDY; KOREAN MEDICINE; MALE; MELANOMA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; SURVIVAL RATE; TUMOR VOLUME; VISCUM ALBUM; ANIMAL; CELL CYCLE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; MELANOMA, EXPERIMENTAL; METABOLISM; MISTLETOE; ORAL DRUG ADMINISTRATION; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CASPASE 8; CELL CYCLE; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; IN VITRO TECHNIQUES; MELANOMA, EXPERIMENTAL; MICE; MISTLETOE; PLANT EXTRACTS; PLANT LECTINS; POLYMERS; RIBOSOME INACTIVATING PROTEINS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84941992640     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2484-1     Document Type: Article

References (54)

1. Pan-In P, Wanichwecharungruang S, Hanes J, Kim AJ (2014) Cellular trafficking and anticancer activity of Garcinia mangostana extract-encapsulated polymeric nanoparticles. Int J Nanomed 9:3677–3686
2. Engel N, Falodun A, Kuhn J, Kragl U, Langer P, Nebe B (2014) Pro-apoptotic and anti-adhesive effects of four African plant extracts on the breast cancer cell line MCF-7. BMC Complement Altern Med 14:334
3. Cragg GM, Newman DJ (2000) Antineoplastic agents from natural sources: achievements and future directions. Expert Opin Investig Drugs 9:2783–2797
4. Seifert G, Jesse P, Laengler A, Reindl T, Lüth M, Lobitz S, Henze G, Prokop A, Lode HN (2008) Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro. Cancer Lett 264:218–228
5. Gardin NE (2009) Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series. Phytother Res 23:407–411
6. Hostanska K, Hajto T, Spagnoli GC, Fischer J, Lentzen H, Herrman R (1995) A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells. Nat Immun 14:295–304
7. Büssing A, Vervecken W, Wagner M, Wagner B, Pfüller U, Schietzel M (1999) Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins and the cell membrane permeabilizing viscotoxins. Cytometry 37:133–139
8. Lyu SY, Park SM, Choung BY, Park WB (2000) Comparative study of Korean (Viscum album var. coloratum) and European mistletoes (Viscum album). Arch Pharm Res 23:592–598
9. Kim MS, So HS, Lee KM, Park JS, Lee JH, Moon SK, Ryu DG, Chung SY, Jung BH, Kim YK, Moon G, Park R (2000) Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells. Gen Pharmacol 34:349–355
10. Pae HO, Seo WG, Shin M, Lee HS, Kim SB, Chung HT (2000) Protein kinase A or C modulates the apoptosis induced by lectin II isolated from Korean mistletoe, Viscum album var. Coloratum, in the human leukemic HL-60 cells. Immunopharmacol Immunotoxicol 22:279–295
11. Pae HO, Oh GS, Kim NY, Shin MK, Lee HS, Yun YG, Oh H, Kim YM, Chung HT (2001) Roles of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in apoptosis of human monoblastic leukemia U937 cells by lectin-II isolated from Korean mistletoe. In Vitr Mol Toxicol 14:99–106
12. Lyu SY, Park WB, Choi KH, Kim WH (2001) Involvement of caspase-3 in apoptosis induced by Viscum album var. coloratum agglutinin in HL-60 cells. Biosci Biotechnol Biochem 65:534–541
13. Lyu SY, Choi JH, Lee HJ, Park WB, Kim GJ (2013) Korean mistletoe lectin promotes proliferation and invasion of trophoblast cells through regulation of Akt signaling. Reprod Toxicol 39:33–39
14. Bussing A, Suzart K, Bergmann J, Pfuller U, Schietzel M, Schweizer K (1996) Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett 99:59–72
15. Bantel H, Engels IH, Voelter W, Schulze-Osthoff K, Wesselborg S (1999) Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res 59:2083–2090
16. Lyu SY, Kwon YJ, Joo HJ, Park WB (2004) Preparation of alginate/chitosan microcapsules and enteric coated granules of mistletoe lectin. Arch Pharm Res 27:118–126
17. Zhou J, Liu R, Wang Y, Tang J, Tang S, Chen X, Xia K, Xiong W, Xu D, Wang S, He Q, Cao K (2014) miR-199a-5p regulates the expression of metastasis-associated genes in B16F10 melanoma cells. Int J Clin Exp Pathol 7:7182–7190
18. Xu D, Tan J, Zhou M, Jiang B, Xie H, Nie X, Xia K, Zhou J (2012) Let-7b and microRNA-199a inhibit the proliferation of B16F10 melanoma cells. Oncol Lett 4:941–946
19. Park HJ (2014) CARI III inhibits tumor growth in a melanoma-bearing mouse model through induction of G0/G1 cell cycle arrest. Molecules 19:14383–14395
20. Hoang MT, Eichenfield LF (2000) The rising incidence of melanoma in children and adolescents. Dermatol Nurs 12(188–9):192–193
21. Chen CC, Hsieh DS, Huang KJ, Chan YL, Hong PD, Yeh MK, Wu CJ (2014) Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells. Drug Des Devel Ther 8:459–474
22. Guevara-Canales JO, Gutierrez-Morales MM, Sacsaquispe-Contreras SJ, Sanchez-Lihon J, Morales-Vadillo R (2012) Malignant melanoma of the oral cavity. Review of the literature and experience in a Peruvian population. Med Oral Patol Oral Cir Bucal 17:e206–e211
23. Pusceddu S, Bajetta E, Carcangiu ML, Formisano B, Ducceschi M, Buzzoni R (2012) A literature overview of primary cervical malignant melanoma: an exceedingly rare cancer. Crit Rev Oncol Hematol 81:185–195
24. Vikey AK, Vikey D (2012) Primary malignant melanoma, of head and neck: a comprehensive review of literature. Oral Oncol 48:399–403
25. Kato Y, Yoshino I, Egusa C, Maeda T, Pili R, Tsuboi R (2014) Combination of HDAC inhibitor MS-275 and IL-2 increased anti-tumor effect in a melanoma model via activated cytotoxic T cells. J Dermatol Sci 75:140–147
26. Wang J, Yang Z, Wen J, Ma F, Wang F, Yu K, Tang M, Wu W, Dong Y, Cheng X, Nie C, Chen L (2014) SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation. J Pharmacol Sci 126:198–207
27. Kamei N, Morishita M, Ehara J, Takayama K (2008) Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery. J Control Release 131:94–99
28. Pryme IF, Bardocz S, Pusztai A, Ewen SW (2002) Dietary mistletoe lectin supplementation and reduced growth of a murine non-Hodgkin lymphoma. Histol Histopathol 17:261–271
29. Pusztai A, Grant G, Gelencsér E, Ewen SWB, Pfüller U, Eifler R, Bardocz S (1998) Effects of an orally administered mistletoe (Type-2 RIP) lectin on growth, body composition, small intestinal structure, and insulin levels in young rats. J Nutr Biochem 9:31–36
30. Lyu SY, Park WB (2008) Transport of mistletoe lectin by M cells in human intestinal follicle-associated epithelium (FAE) in vitro. Arch Pharm Res 31:1613–1621
31. Lyu SY, Park WB (2009) Mistletoe lectin modulates intestinal epithelial cell-derived cytokines and B cell IgA secretion. Arch Pharm Res 32:443–451
32. Hong CE, Park AK, Lyu SY (2014) Synergistic anticancer effects of lectin and doxorubicin in breast cancer cells. Mol Cell Biochem 394:225–235
33. Ishiguro T, Nakajima M, Naito M, Muto T, Tsuruo T (1996) Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res 56:875–879
34. Fidler IJ (1973) Selection of successive tumour lines for metastasis. Nat New Biol 242:148–149
35. Poste G, Doll J, Hart IR, Fidler IJ (1980) In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res 40:1636–1644
36. Park DK, Lim YH, Park HJ (2013) Antrodia camphorata grown on germinated brown rice inhibits HT-29 human colon carcinoma proliferation through inducing G0/G1 phase arrest and apoptosis by targeting the beta-catenin signaling. J Med Food 16:681–691
37. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326:1–16
38. Rupachandra S, Sarada DV (2014) Induction of apoptotic effects of antiproliferative protein from the seeds of Borreria hispida on lung cancer (A549) and cervical cancer (HeLa) cell lines. Biomed Res Int 2014:179836
39. Tonevitsky AG, Agapov II, Pevzner IB, Malyuchenko NV, Moisenovich MM, Pfueller U, Kirpichnikov MP (2004) Cloning and expression of catalytic subunit of MLIII, the ribosome-inactivating protein from Viscum album. Biochemistry (Mosc) 69:642–650
40. Kim HS, Kim TJ, Yoo YM (2014) Melatonin combined with endoplasmic reticulum stress induces cell death via the PI3K/Akt/mTOR pathway in B16F10 melanoma cells. PLoS ONE 9:e92627
41. Slominski A, Tobin DJ, Shibahara S, Wortsman J (2004) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84:1155–1228
42. Liang KV, Sanderson SO, Nowakowski GS, Arora AS (2006) Metastatic malignant melanoma of the gastrointestinal tract. Mayo Clin Proc 81:511–516
43. Kivela T, Kujala E (2013) Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond. Eye (Lond) 27:243–252
44. Wang X, He X, Zhao F, Wang J, Zhang H, Shi F, Zhang Y, Cai K, Dou J (2014) Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis. J Transl Med 12:68
45. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM, Morrison SJ (2010) Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18:510–523
46. Romano S, Staibano S, Greco A, Brunetti A, Nappo G, Ilardi G, Martinelli R, Sorrentino A, Di Pace A, Mascolo M, Bisogni R, Scalvenzi M, Alfano B, Romano MF (2013) FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential. Cell Death Dis 4:e578
47. Dukic-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C (2008) In-vitro and in vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Eur J Pharm Biopharm 70:302–312
48. Erkoboni KA (1997) Extrusion/spheronisation. In: Parikh D (ed) Handbook of pharmaceutical technology. Marcel Dekker Inc, New York, pp 277–322
49. Zhang X, Wang Y, Wang J, Li S (2007) Effect of pore former on the properties of casted film prepared from blends of Eudragit NE 30 D and Eudragit L 30 D-55. Chem Pharm Bull (Tokyo) 55:1261–1263
50. Overwijk WW, Restifo NP (2001) B16 as a mouse model for human melanoma. Curr Protoc Immunol Chapter 20:Unit 20 1
51. Sherr CJ (2004) Principles of tumor suppression. Cell 116:235–246
52. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312–1316
53. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305–1308
54. Cryns V, Yuan J (1998) Proteases to die for. Genes Dev 12:1551–1570